HIGHLIGHTS
- who: Anna M. Romanov et al. from the DepartmentCambridge, MA, USA have published the research work: The past, present, and future of human challenge trials, in the Journal: (JOURNAL) of August/29,/2022
- what: Human challenge trials offer a unique opportunity to learn about disease transmission and test early vaccine and drug candidates, reducing the overall number of volunteers and enabling certain immunological readouts that may not Romanov and Hong be possible with standard clinical trial models.
SUMMARY
One such HCT was designed for cholera, which is considered an ideal disease . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.